{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:39:59Z","timestamp":1790386799539,"version":"4.1.0"},"reference-count":187,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/2\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["IRP-NIMH-NIH"],"award-info":[{"award-number":["IRP-NIMH-NIH"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA MH002857"],"award-info":[{"award-number":["ZIA MH002857"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/ijnp\/pyy094","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T15:11:11Z","timestamp":1542208271000},"page":"119-135","source":"Crossref","is-referenced-by-count":154,"title":["Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments"],"prefix":"10.1093","volume":"22","author":[{"given":"Bashkim","family":"Kadriu","sequence":"first","affiliation":[{"name":"Section on the Neurobiology and Treatment of Mood Disorders, Intramural Research Program, National Institute of Mental Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Musazzi","sequence":"additional","affiliation":[{"name":"Laboratory of Neuropsychopharmacology and Functional Neurogenomics \u2013 Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases, University of Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioline D","family":"Henter","sequence":"additional","affiliation":[{"name":"Section on the Neurobiology and Treatment of Mood Disorders, Intramural Research Program, National Institute of Mental Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Graves","sequence":"additional","affiliation":[{"name":"Section on the Neurobiology and Treatment of Mood Disorders, Intramural Research Program, National Institute of Mental Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Popoli","sequence":"additional","affiliation":[{"name":"Laboratory of Neuropsychopharmacology and Functional Neurogenomics \u2013 Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases, University of Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Carlos A","family":"Zarate","sequence":"additional","affiliation":[{"name":"Section on the Neurobiology and Treatment of Mood Disorders, Intramural Research Program, National Institute of Mental Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"key\n\t\t\t\t2019020813294326700_CIT0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"Aan het Rot","year":"2010","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0002","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biopsych.2012.05.003","article-title":"Ketamine for depression: where do we go from here","volume":"72","author":"Aan Het Rot","year":"2012","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0003","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bpsc.2017.04.006","article-title":"Prefrontal connectivity and glutamate transmission: relevance to depression pathophysiology and ketamine treatment","volume":"2","author":"Abdallah","year":"2017","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0004","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/npp.2016.186","article-title":"Ketamine treatment and global brain connectivity in major depression","volume":"42","author":"Abdallah","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2018.05.010","article-title":"The neurobiology of depression, ketamine and rapid-acting antidepressants: is it glutamate inhibition or activation","volume":"190","author":"Abdallah","year":"2018","journal-title":"Pharmacol Ther"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0006","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbr.2014.05.003","article-title":"Blockade of the metabotropic glutamate (mglur2) modulates arousal through vigilance states transitions: evidence from sleep-wake EEG in rodents","volume":"270","author":"Ahnaou","year":"2014","journal-title":"Behav Brain Res"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0007","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1176\/ajp.150.11.1731","article-title":"Plasma and platelet excitatory amino acids in psychiatric disorders","volume":"150","author":"Altamura","year":"1993","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0008","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2018.04.022","article-title":"Temporally dissociable effects of ketamine on neuronal discharge and gamma oscillations in rat thalamo-cortical networks","volume":"137","author":"Amat-Foraster","year":"2018","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0009","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.biopsych.2016.02.014","article-title":"Ketamine\u2019s antidepressant actions: potential mechanisms in the primate medial prefrontal circuits that represent aversive experience","volume":"79","author":"Arnsten","year":"2016","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0006-3223(99)00159-6","article-title":"Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study","volume":"47","author":"Auer","year":"2000","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0012","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/npp.2012.5","article-title":"Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a spatial code for BDNF splice variants","volume":"37","author":"Baj","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0013","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/mp.2008.106","article-title":"Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole","volume":"15","author":"Banasr","year":"2010","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0014","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.biopsych.2014.04.014","article-title":"Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity","volume":"76","author":"Belujon","year":"2014","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0015","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","article-title":"Dopamine system dysregulation in major depressive disorders","volume":"20","author":"Belujon","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0016","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0017","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/mp.2008.119","article-title":"The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling","volume":"14","author":"Bessa","year":"2009","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0018","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.biopsych.2012.05.028","article-title":"Effects of ketamine in treatment-refractory obsessive-compulsive disorder","volume":"72","author":"Bloch","year":"2012","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0019","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/archpsyc.1965.01730060001001","article-title":"Norepinephrine in depressive reactions. A review","volume":"13","author":"Bunney","year":"1965","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0020","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/npp.2012.246","article-title":"GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects","volume":"38","author":"Burgdorf","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0021","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuroscience.2015.09.004","article-title":"The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus","volume":"308","author":"Burgdorf","year":"2015","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0022","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","article-title":"Mechanisms of gamma oscillations","volume":"35","author":"Buzs\u00e1ki","year":"2012","journal-title":"Annu Rev Neurosci"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0023","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/2045125313507739","article-title":"Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy","volume":"4","author":"Caddy","year":"2014","journal-title":"Ther Adv Psychopharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0024","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","article-title":"Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study","volume":"175","author":"Canuso","year":"2018","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0025","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.4088\/JCP.10126tx1c","article-title":"Understanding the burden of depression","volume":"72","author":"Culpepper","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0026","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/npp.2014.256","article-title":"Lateral diffusion of g\u03b1s in the plasma membrane is decreased after chronic but not acute antidepressant treatment: role of lipid raft and non-raft membrane microdomains","volume":"40","author":"Czysz","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0027","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0028","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/npp.2014.26","article-title":"Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks","volume":"39","author":"Dawson","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0029","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881114527361","article-title":"Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic","volume":"28","author":"Diamond","year":"2014","journal-title":"J Psychopharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0030","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"DiazGranados","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0031","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0032","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1523\/JNEUROSCI.5713-07.2008","article-title":"Postmortem brain tissue of depressed suicides reveals increased gs alpha localization in lipid raft domains where it is less likely to activate adenylyl cyclase","volume":"28","author":"Donati","year":"2008","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0033","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.npp.1301178","article-title":"The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders","volume":"32","author":"Du","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0034","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0036","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","article-title":"Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial","volume":"71","author":"Feder","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0037","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jad.2008.10.014","article-title":"What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies","volume":"116","author":"Fekadu","year":"2009","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0038","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/B:CEMN.0000012717.37839.07","article-title":"Riluzole enhances glutamate uptake in rat astrocyte cultures","volume":"24","author":"Frizzo","year":"2004","journal-title":"Cell Mol Neurobiol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0039","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.biopsych.2010.11.031","article-title":"Dose- and exposure-response to ketamine in depression","volume":"70","author":"Glue","year":"2011","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0040","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.neuron.2011.08.007","article-title":"Distinct modes of AMPA receptor suppression at developing synapses by glun2a and glun2b: single-cell NMDA receptor subunit deletion in vivo","volume":"71","author":"Gray","year":"2011","journal-title":"Neuron"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0041","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.14m09298","article-title":"The economic burden of adults with major depressive disorder in the United States (2005 and 2010)","volume":"76","author":"Greenberg","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0042","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/j.amepre.2014.06.012","article-title":"Existing and novel biological therapeutics in suicide prevention","volume":"47","author":"Griffiths","year":"2014","journal-title":"Am J Prev Med"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0043","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s13311-017-0527-x","article-title":"Neural substrates of depression and resilience","volume":"14","author":"Han","year":"2017","journal-title":"Neurotherapeutics"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0044","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00213-017-4786-3","article-title":"Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study","volume":"235","author":"Hartberg","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","article-title":"Reduced prefrontal glutamate\/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy","volume":"64","author":"Hasler","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0046","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1055\/s-2007-979535","article-title":"The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans","volume":"29","author":"Heninger","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0047","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jad.2006.03.004","article-title":"Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder","volume":"93","author":"Heresco-Levy","year":"2006","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0048","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1461145712000910","article-title":"A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression","volume":"16","author":"Heresco-Levy","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0049","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2013.02.020","article-title":"Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression","volume":"74","author":"Huang","year":"2013","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2040622315579059","article-title":"Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review","volume":"6","author":"Iadarola","year":"2015","journal-title":"Ther Adv Chronic Dis"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0051","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2011.03.019","article-title":"Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression","volume":"35","author":"Ibrahim","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0052","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/JCP.0b013e31825d70d6","article-title":"A randomized, placebo-controlled, crossover pilot trial of the oral selective NR2b antagonist MK-0657 in patients with treatment-resistant major depressive disorder","volume":"32","author":"Ibrahim","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0053","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/npp.2011.338","article-title":"Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study","volume":"37","author":"Ibrahim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0054","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbr.2012.08.016","article-title":"Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test","volume":"235","author":"Iijima","year":"2012","journal-title":"Behav Brain Res"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0055","volume-title":"Director\u2019s Blog: Ketamine","author":"Insel TR","year":"2014"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0056","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1176\/appi.ajp.2014.14020138","article-title":"The NIMH research domain criteria (RDoC) project: precision medicine for psychiatry","volume":"171","author":"Insel","year":"2014","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0057","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jad.2018.09.037","article-title":"Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: a randomized, double blind, placebo controlled trial","volume":"243","author":"Ionescu","year":"2019","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0058","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1089\/jpm.2012.0617","article-title":"Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial","volume":"16","author":"Irwin","year":"2013","journal-title":"J Palliat Med"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0059","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/JCP.0000000000000866","article-title":"Clinical trial of the potassium channel activator diazoxide for major depressive disorder halted due to intolerability","volume":"38","author":"Kadriu","year":"2018","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0060","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","article-title":"Large-scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity","volume":"72","author":"Kaiser","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0061","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4088\/JCP.14l09527","article-title":"Single-dose ketamine followed by daily D-cycloserine in treatment-resistant bipolar depression","volume":"76","author":"Kantrowitz","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0062","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2005.02.032","article-title":"AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist","volume":"1042","author":"Karasawa","year":"2005","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0063","article-title":"BDNF release and signaling are required for the antidepressant actions of GLYX-13","author":"Kato","year":"2017","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0064","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1176\/appi.ajp.2016.15081101","article-title":"Right unilateral ultrabrief pulse ECT in geriatric depression: phase 1 of the PRIDE study","volume":"173","author":"Kellner","year":"2016","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0065","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1176\/appi.ajp.2016.16010118","article-title":"A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE study","volume":"173","author":"Kellner","year":"2016","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0066","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jad.2014.05.050","article-title":"The utility of the combination of dextromethorphan and quinidine in the treatment of bipolar II and bipolar NOS","volume":"167","author":"Kelly","year":"2014","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0067","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pnpbp.2016.01.009","article-title":"Efficacy and safety of an adjunctive mglu2 receptor positive allosteric modulator to a SSRI\/SNRI in anxious depression","volume":"67","author":"Kent","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0068","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/jcp.22609","article-title":"Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics","volume":"226","author":"Kim","year":"2011","journal-title":"J Cell Physiol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0069","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol Med"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","article-title":"Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression","volume":"224","author":"Koike","year":"2011","journal-title":"Behav Brain Res"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0071","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/mp.2017.190","article-title":"The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders","volume":"23","author":"Kokkinou","year":"2018","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0072","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1038\/tp.2014.105","article-title":"Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression","volume":"4","author":"Lally","year":"2014","journal-title":"Transl Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0073","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026","article-title":"A randomized controlled trial of intranasal ketamine in major depressive disorder","volume":"76","author":"Lapidus","year":"2014","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0074","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1017\/S1461145713000485","article-title":"Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression","volume":"16","author":"Lara","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0075","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.mehy.2011.02.003","article-title":"Dextromethorphan as a potential rapid-acting antidepressant","volume":"76","author":"Lauterbach","year":"2011","journal-title":"Med Hypotheses"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0076","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.mehy.2012.02.012","article-title":"An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan","volume":"78","author":"Lauterbach","year":"2012","journal-title":"Med Hypotheses"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0077","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/mp.2016.81","article-title":"Disrupted habenula function in major depression","volume":"22","author":"Lawson","year":"2017","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0078","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1162\/jocn.2009.21305","article-title":"Ketamine modulates theta and gamma oscillations","volume":"22","author":"Lazarewicz","year":"2010","journal-title":"J Cogn Neurosci"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0079","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuropharm.2013.04.005","article-title":"BDNF-induced local protein synthesis and synaptic plasticity","volume":"76 Pt C","author":"Leal","year":"2014","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jad.2012.01.024","article-title":"The DRD2\/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder","volume":"138","author":"Lee","year":"2012","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0081","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.biopsych.2016.05.005","article-title":"Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine","volume":"81","author":"Lener","year":"2017","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0082","doi-asserted-by":"crossref","first-page":"pyu033","DOI":"10.1093\/ijnp\/pyu033","article-title":"BDNF release is required for the behavioral actions of ketamine","volume":"18","author":"Lepack","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0083","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature09742","article-title":"Synaptic potentiation onto habenula neurons in the learned helplessness model of depression","volume":"470","author":"Li","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0084","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"Mtor-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0085","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0086","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biopsych.2011.09.030","article-title":"Brain-derived neurotrophic factor val66met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex","volume":"71","author":"Liu","year":"2012","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0087","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/npp.2016.202","article-title":"GLYX-13 produces rapid antidepressant responses with key synaptic and behavioral effects distinct from ketamine","volume":"42","author":"Liu","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0088","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1101\/lm.54603","article-title":"BDNF and activity-dependent synaptic modulation","volume":"10","author":"Lu","year":"2003","journal-title":"Learn Mem"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0089","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.biopsych.2015.02.028","article-title":"Large-scale persistent network reconfiguration induced by ketamine in anesthetized monkeys: relevance to mood disorders","volume":"79","author":"Lv","year":"2016","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0090","doi-asserted-by":"crossref","first-page":"e56053","DOI":"10.1371\/journal.pone.0056053","article-title":"Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0091","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharmthera.2009.02.010","article-title":"Ketamine and the next generation of antidepressants with a rapid onset of action","volume":"123","author":"Machado-Vieira","year":"2009","journal-title":"Pharmacol Ther"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0092","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/eb-2015-102299","article-title":"Is treatment-resistant depression a useful concept","volume":"19","author":"Malhi","year":"2016","journal-title":"Evid Based Ment Health"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0093","doi-asserted-by":"crossref","first-page":"pyv069","DOI":"10.1093\/ijnp\/pyv069","article-title":"Expression and dendritic trafficking of BDNF-6 splice variant are impaired in knock-in mice carrying human BDNF Val66Met polymorphism","volume":"18","author":"Mallei","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0094","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00213-015-4175-8","article-title":"Ketamine-induced brain activation in awake female nonhuman primates: a translational functional imaging model","volume":"233","author":"Maltbie","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0095","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1038\/npp.2017.106","article-title":"A randomized, double-blind, placebo-controlled, sequential parallel comparison design trial of adjunctive riluzole for treatment-resistant major depressive disorder","volume":"42","author":"Mathew","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0096","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","article-title":"Deep brain stimulation for treatment-resistant depression","volume":"45","author":"Mayberg","year":"2005","journal-title":"Neuron"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0097","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1017\/S0033291714001603","article-title":"A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes","volume":"45","author":"McGirr","year":"2015","journal-title":"Psychol Med"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0098","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2013.10.043","article-title":"Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach","volume":"156","author":"McIntyre","year":"2014","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0099","first-page":"PCC.12I01400","article-title":"Dextromethorphan and quinidine combination in emotional lability associated with depression: a case report","volume":"14","author":"Messias","year":"2012","journal-title":"Prim Care Companion CNS Disord"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0100","doi-asserted-by":"crossref","first-page":"e03581","DOI":"10.7554\/eLife.03581","article-title":"Glun2b-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine","volume":"3","author":"Miller","year":"2014","journal-title":"Elife"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0101","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuropharm.2015.07.028","article-title":"Two cellular hypotheses explaining the initiation of ketamine\u2019s antidepressant actions: direct inhibition and disinhibition","volume":"100","author":"Miller","year":"2016","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0102","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.celrep.2017.08.002","article-title":"Synaptic regulation of a thalamocortical circuit controls depression-related behavior","volume":"20","author":"Miller","year":"2017","journal-title":"Cell Rep"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0103","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cns.12099","article-title":"Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)","volume":"19","author":"Mion","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0104","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(01)02098-5","article-title":"Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes","volume":"310","author":"Mizuta","year":"2001","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0105","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.talanta.2010.08.005","article-title":"A parallel chiral-achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome","volume":"82","author":"Moaddel","year":"2010","journal-title":"Talanta"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0106","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0107","doi-asserted-by":"crossref","DOI":"10.1007\/s40263-018-0519-3","article-title":"Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review","author":"Molero","year":"2018","journal-title":"CNS Drugs"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0108","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.biopsych.2012.09.006","article-title":"The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine","volume":"73","author":"Monteggia","year":"2013","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0109","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/515200a","article-title":"Depression: the best way forward","volume":"515","author":"Monteggia","year":"2014","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0110","doi-asserted-by":"crossref","first-page":"e1146","DOI":"10.1038\/tp.2017.120","article-title":"The modulation of adult neuroplasticity is involved in the mood-improving actions of atypical antipsychotics in an animal model of depression","volume":"7","author":"Morais","year":"2017","journal-title":"Transl Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0111","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/13543784.2014.852536","article-title":"GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists","volume":"23","author":"Moskal","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0112","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0113","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0114","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychol Med"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0115","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrd.2017.16","article-title":"Targeting glutamate signalling in depression: progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0116","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jad.2017.04.072","article-title":"Dextromethorphan\/quinidine pharmacotherapy in patients with treatment resistant depression: a proof of concept clinical trial","volume":"218","author":"Murrough","year":"2017","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0117","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.biopsych.2012.11.009","article-title":"The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors","volume":"73","author":"Musazzi","year":"2013","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0118","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.tins.2017.07.002","article-title":"Acute or chronic? A stressful question","volume":"40","author":"Musazzi","year":"2017","journal-title":"Trends Neurosci"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0119","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbr.2015.03.024","article-title":"Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice","volume":"295","author":"Nguyen","year":"2015","journal-title":"Behav Brain Res"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0121","doi-asserted-by":"crossref","first-page":"e89985","DOI":"10.1371\/journal.pone.0089985","article-title":"Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan","volume":"9","author":"Nguyen","year":"2014","journal-title":"Plos One"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0122","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-018-0028-2","article-title":"Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects","author":"Nugent","year":"2018","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0123","doi-asserted-by":"crossref","first-page":"e48002","DOI":"10.1371\/journal.pone.0048002","article-title":"Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention","volume":"7","author":"Olin","year":"2012","journal-title":"Plos One"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0124","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1054-3589(10)58006-2","article-title":"GABAB receptor coupling to G-proteins and ion channels","volume":"58","author":"Padgett","year":"2010","journal-title":"Adv Pharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuropharm.2014.03.001","article-title":"Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats","volume":"82","author":"Pa\u0142ucha-Poniewiera","year":"2014","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FBP.0000000000000259","article-title":"Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression","volume":"28","author":"Papp","year":"2017","journal-title":"Behav Pharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0127","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000693","article-title":"A double-blind, placebo-controlled, pilot study of riluzole monotherapy for acute bipolar depression","volume":"37","author":"Park","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0128","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s40473-015-0050-5","article-title":"Novel glutamatergic treatments for severe mood disorders","volume":"2","author":"Park","year":"2015","journal-title":"Curr Behav Neurosci Rep"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0129","volume-title":"A randomized, double- blind, placebo-controlled, sequential parallel study of CERC-301 in the adjunctive treatment of subjects with severe depression and recent active suicidal ideation despite antidepressant treatment","author":"Paterson","year":"2015"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0130","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.biopsych.2017.10.020","article-title":"Common neurotransmission recruited in (R,S)-ketamine and (2R,6R)-hydroxynorketamine-induced sustained antidepressant-like effects","volume":"84","author":"Pham","year":"2018","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0131","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1016\/j.biopsych.2018.02.1052","article-title":"Antidepressant effects of single and repeated ketamine infusions in treatment-resistant depression [abstract]","volume":"83","author":"Phillips","year":"2018","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0132","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.pra.0000462606.17725.93","article-title":"Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent","volume":"21","author":"Preskorn","year":"2015","journal-title":"J Psychiatr Pract"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0133","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","article-title":"An innovative design to establish proof of concept of the antidepressant effects of the NR2b subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder","volume":"28","author":"Preskorn","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0134","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0135","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamapsychiatry.2016.0838","article-title":"Efficacy and safety of basimglurant as adjunctive therapy for major depression: a randomized clinical trial","volume":"73","author":"Quiroz","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0136","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/YCT.0000000000000430","article-title":"The PRIDE study and the conduct of electroconvulsive therapy: questions answered and unanswered","volume":"33","author":"Rasmussen","year":"2017","journal-title":"J ECT"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0137","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0269881113478283","article-title":"Serial infusions of low-dose ketamine for major depression","volume":"27","author":"Rasmussen","year":"2013","journal-title":"J Psychopharmacol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0138","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.09262","article-title":"Spontaneous neurotransmission signals through store-driven Ca(2+) transients to maintain synaptic homeostasis","volume":"4","author":"Reese","year":"2015","journal-title":"Elife"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0139","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.biopsych.2016.02.009","article-title":"Bidirectional homeostatic regulation of a depression-related brain state by gamma-aminobutyric acidergic deficits and ketamine treatment","volume":"80","author":"Ren","year":"2016","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0140","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0141","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.psychres.2015.10.032","article-title":"Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression","volume":"230","author":"Romeo","year":"2015","journal-title":"Psychiatry Res"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0142","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0143","first-page":"10","article-title":"The definition and meaning of treatment-resistant depression","volume":"62","author":"Sackeim","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0144","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopha.2016.11.073","article-title":"The role of NMDA receptor and nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effect of dextromethorphan in mice forced swimming test and tail suspension test","volume":"85","author":"Sakhaee","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2016.01.009","article-title":"An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder","volume":"194","author":"Saligan","year":"2016","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0146","volume-title":"Adjunctive lanicemine (AZD6765) in patients with major depressive disorder and a history of inadequate response to antidepressants: primary results from a randomized, placebo controlled study (PURSUIT)","author":"Sanacora","year":"2014"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0147","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/npp.2016.224","article-title":"Adjunctive lanicemine (AZD6765) in patients with major depressive disorder and history of inadequate response to antidepressants: a randomized, placebo-controlled study","volume":"42","author":"Sanacora","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0148","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/npp.2014.261","article-title":"Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders","volume":"40","author":"Sanacora","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0149","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0150","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0151","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","article-title":"The catecholamine hypothesis of affective disorders: a review of supporting evidence","volume":"122","author":"Schildkraut","year":"1965","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0152","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0028-3908(01)00073-9","article-title":"Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine","volume":"41","author":"Sheinin","year":"2001","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0153","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuroscience.2018.05.037","article-title":"Effects of low doses of ketamine on pyramidal neurons in rat prefrontal cortex","volume":"384","author":"Shen","year":"2018","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0154","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2013.10.036","article-title":"Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression","volume":"155","author":"Shiroma","year":"2014","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0155","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2015.10.018","article-title":"Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study","volume":"80","author":"Singh","year":"2016","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0156","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0157","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/mp.2017.144","article-title":"BDNF at the synapse: why location matters","volume":"22","author":"Song","year":"2017","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0158","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jcpt.12497","article-title":"What is the mechanism of ketamine\u2019s rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities","volume":"42","author":"Strasburger","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0159","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature22084","article-title":"Effects of a ketamine metabolite on synaptic NMDAR function","volume":"546","author":"Suzuki","year":"2017","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tins.2015.03.003","article-title":"An excitatory synapse hypothesis of depression","volume":"38","author":"Thompson","year":"2015","journal-title":"Trends Neurosci"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0161","doi-asserted-by":"crossref","DOI":"10.1016\/S0924-977X(17)31022-2","volume-title":"Ketamine restores changes in glutamate release, BDNF trafficking and dendrite morphology in the hippocampus of rats vulnerable to chronic mild stress","author":"Tornese","year":"2017"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0162","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0163","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1046\/j.1460-9568.2000.00242.x","article-title":"Riluzole inhibits the persistent sodium current in mammalian CNS neurons","volume":"12","author":"Urbani","year":"2000","journal-title":"Eur J Neurosci"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0164","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.sjpain.2017.05.004","article-title":"Randomized, double-blind, placebo-controlled, dose-escalation study: investigation of the safety, pharmacokinetics, and antihyperalgesic activity of l-4-chlorokynurenine in healthy volunteers","volume":"17","author":"Wallace","year":"2017","journal-title":"Scand J Pain"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0166","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.13m08852","article-title":"Ketamine safety and tolerability in clinical trials for treatment-resistant depression","volume":"76","author":"Wan","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0167","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12264-014-1504-6","article-title":"Contribution of NMDA receptors to dorsolateral prefrontal cortical networks in primates","volume":"31","author":"Wang","year":"2015","journal-title":"Neurosci Bull"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0168","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0169","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1124\/jpet.116.233627","article-title":"The rapidly acting antidepressant ketamine and the mglu2\/3 receptor antagonist LY341495 rapidly engage dopaminergic mood circuits","volume":"358","author":"Witkin","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0171","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neuropharm.2013.05.037","article-title":"mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling","volume":"73","author":"Workman","year":"2013","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0172","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/mp.2017.225","article-title":"Engaging homeostatic plasticity to treat depression","volume":"23","author":"Workman","year":"2018","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0173","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-018-0083-8","article-title":"NMDAR-independent, cAMP-dependent antidepressant actions of ketamine","author":"Wray","year":"2018","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0174","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.conb.2017.10.024","article-title":"Lateral habenula in the pathophysiology of depression","volume":"48","author":"Yang","year":"2018","journal-title":"Curr Opin Neurobiol"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0176","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature25509","article-title":"Ketamine blocks bursting in the lateral habenula to rapidly relieve depression","volume":"554","author":"Yang","year":"2018","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pscychresns.2005.12.004","article-title":"Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis","volume":"147","author":"Yildiz-Yesiloglu","year":"2006","journal-title":"Psychiatry Res"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0178","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0179","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40263-018-0492-x","article-title":"Convergent mechanisms underlying rapid antidepressant action","volume":"32","author":"Zanos","year":"2018","journal-title":"CNS Drugs"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0181","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol Rev"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0182","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1176\/appi.ajp.161.1.171","article-title":"An open-label trial of riluzole in patients with treatment-resistant major depression","volume":"161","author":"Zarate","year":"2004","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0183","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0184","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2012.03.004","article-title":"Relationship of ketamine\u2019s plasma metabolites with response, diagnosis, and side effects in major depression","volume":"72","author":"Zarate","year":"2012","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0185","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine\u2019s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0186","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biopsych.2012.10.019","article-title":"A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression","volume":"74","author":"Zarate","year":"2013","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019020813294326700_CIT0187","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol Biochem Behav"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/22\/2\/119\/27738690\/pyy094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T04:48:10Z","timestamp":1572670090000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/22\/2\/119\/5185216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":187,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,11,16]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyy094","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,11,16]]}}}